AC Immune signs collaboration agreement with Nestlé Institute of Health Sciences to develop Alzheimer's disease diagnostic

Sep 23, 2015
  • Development of minimally invasive Tau diagnostic assay for Alzheimer's disease
  • Potential to identify Alzheimer's patients at very early and potentially pre-symptomatic stage of the disease
  • Neurodegenerative expertise endorsed by fourth Tau collaboration